Understanding What is a Neutropenic Fever Classification?
•
1 min read
Approximately 13% to 21% of patients with solid tumors receiving myelosuppressive chemotherapy will experience febrile neutropenia. A crucial aspect of managing this condition involves understanding **what is a neutropenic fever classification**, which helps determine the appropriate level of care and treatment plan.
